Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 1,292 | 1,090 | 1,460 | 2,550 |
| Gross Profit | N/A | 1,292 | 1,090 | 1,460 | 2,550 |
| Operating Expenses | 20,436 | 51,688 | 20,327 | 28,662 | 27,570 |
| Operating Income | -20,436 | -50,396 | -19,237 | -27,202 | -25,020 |
| Other Income | 906 | 990 | 1,176 | 1,433 | 1,633 |
| Pre-tax Income | -19,530 | -49,406 | -18,061 | -25,769 | -23,387 |
| Income Tax | 95 | 636 | N/A | 1 | N/A |
| Net Income Continuous | -19,625 | -50,042 | -18,061 | -25,770 | -23,387 |
| Net Income | $-19,625 | $-50,042 | $-18,061 | $-25,770 | $-23,387 |
| EPS Basic Total Ops | -1.69 | -5.33 | -1.92 | -2.74 | -2.49 |
| EPS Basic Continuous Ops | -1.69 | -5.32 | -1.92 | -2.74 | -2.49 |
| EPS Diluted Total Ops | -1.69 | -5.33 | -1.92 | -2.74 | -2.49 |
| EPS Diluted Continuous Ops | -1.69 | -5.32 | -1.92 | -2.74 | -2.49 |
| EPS Diluted Before Non-Recurring Items | -1.69 | -5.32 | -1.92 | -2.74 | -2.49 |
| EBITDA(a) | $-20,054 | $-49,769 | $-18,105 | $-26,055 | $-24,135 |